Mediar Therapeutics
My lab studies the biological mechanisms that cause liver fibrosis and liver cancer. We have a particular interest in developing novel models and imaging techniques to study these diseases in order to evaluate new therapies and identify effective biomarkers.
This person is not in the org chart
This person is not in any offices
Mediar Therapeutics
Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.